{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2013-N-0002\" sorted by posted_date descending", "rows": [["FDA-2013-N-0002-0057", "FDA", "FDA-2013-N-0002", "Pulmotil AC (aqueous tilmicosin) Environmental Assessment for the Use of Pulmotil AC to Control Swine Respiratory Disease", "Other", "Background Material", "2014-04-09T04:00:00Z", 2014, 4, "2014-04-09T04:00:00Z", null, "2014-04-09T12:45:38Z", null, 0, 0, "09000064816aa8f6"], ["FDA-2013-N-0002-0058", "FDA", "FDA-2013-N-0002", "ENVIRONMENTAL ASSESSMENT for AQUAFLOR\uf6da (Florfenicol) 50% Type A Medicated Article", "Other", "Background Material", "2014-04-09T04:00:00Z", 2014, 4, "2014-04-09T04:00:00Z", null, "2014-04-09T12:51:55Z", null, 0, 0, "09000064816aa8f7"], ["FDA-2013-N-0002-0056", "FDA", "FDA-2013-N-0002", "Finding of No Significant Impact FONSI For AQUAFLOR Florfenicol\n50 percent Type A Medicated Article", "Other", "Background Material", "2014-04-09T04:00:00Z", 2014, 4, "2014-04-09T04:00:00Z", null, "2014-04-09T12:40:34Z", null, 0, 0, "09000064816aa8f5"], ["FDA-2013-N-0002-0059", "FDA", "FDA-2013-N-0002", "Finding of No Significant Impact (FONSI) for PULMOTIL AC Aqueous Concentrate (Tilmicosin) in Swine for the Control of Swine Respiratory Disease", "Other", "Background Material", "2014-04-09T04:00:00Z", 2014, 4, "2014-04-09T04:00:00Z", null, "2014-04-09T12:55:59Z", null, 0, 0, "09000064816aa8f8"], ["FDA-2013-N-0002-0052", "FDA", "FDA-2013-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 141-361\nPULMOTIL AC Tilmicosin Phosphate Aqueous Concentrate\nSwine", "Supporting & Related Material", "Freedom of Information Summary", "2014-04-08T04:00:00Z", 2014, 4, null, null, "2014-04-08T16:29:38Z", null, 0, 0, "09000064816a892c"], ["FDA-2013-N-0002-0053", "FDA", "FDA-2013-N-0002", "FREEDOM OF INFORMATION SUMMARY  NADA141-420 TILDREN\ntiludronate disodium Powder for injection Horse", "Supporting & Related Material", "Freedom of Information Summary", "2014-04-08T04:00:00Z", 2014, 4, null, null, "2014-04-08T16:32:40Z", null, 0, 0, "09000064816a892d"], ["FDA-2013-N-0002-0055", "FDA", "FDA-2013-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 130-185\nAMPROL 25% and FLAVOMYCIN Amprolium and Bambermycins", "Supporting & Related Material", "Freedom of Information Summary", "2014-04-08T04:00:00Z", 2014, 4, null, null, "2014-04-08T16:36:57Z", null, 0, 0, "09000064816a8b80"], ["FDA-2013-N-0002-0054", "FDA", "FDA-2013-N-0002", "FREEDOM OF INFORMATION SUMMARY Application Number 141-422\nPACCAL VET-CA1 Paclitaxel for injection Powder for Injection Dog", "Supporting & Related Material", "Freedom of Information Summary", "2014-04-08T04:00:00Z", 2014, 4, null, null, "2014-04-08T16:35:08Z", null, 0, 0, "09000064816a892e"], ["FDA-2013-N-0002-0051", "FDA", "FDA-2013-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 141-246 AQUAFLOR\nFlorfenicol", "Supporting & Related Material", "Freedom of Information Summary", "2014-04-08T04:00:00Z", 2014, 4, null, null, "2014-04-08T16:22:29Z", null, 0, 0, "09000064816a892b"], ["FDA-2013-N-0002-0050", "FDA", "FDA-2013-N-0002", "New Animal Drugs; Amprolium; Bambermycins; Ceftiofur; Deslorelin;\nFlorfenicol; Florfenicol and Flunixin; Paclitaxel; Phenylbutazone;\nPimobendan; Salinomycin; Tilmicosin; Tiludronate; Change of Sponsor", "Rule", "Final Rule", "2014-04-01T04:00:00Z", 2014, 4, "2014-04-01T04:00:00Z", null, "2014-04-01T13:05:54Z", "2014-07220", 0, 0, "0900006481694311"], ["FDA-2013-N-0002-0048", "FDA", "FDA-2013-N-0002", "Current Good Manufacturing Practice for Medicated Feeds", "Rule", "Final Rule", "2014-01-23T05:00:00Z", 2014, 1, "2014-01-23T05:00:00Z", null, "2014-01-23T17:39:42Z", "2014-01299", 0, 0, "090000648151cdd1"], ["FDA-2013-N-0002-0047", "FDA", "FDA-2013-N-0002", "Withdrawal of Approval of New Animal Drug Applications; Argent\nLaboratories; Formalin; Tricaine Methanesulfonate", "Rule", "Final Rule", "2014-01-16T05:00:00Z", 2014, 1, "2014-01-16T05:00:00Z", null, "2014-01-16T15:17:57Z", "2014-00721", 0, 0, "090000648150d6c6"], ["FDA-2013-N-0002-0046", "FDA", "FDA-2013-N-0002", "Withdrawal of Approval of New Animal Drug Applications; Argent\nLaboratories; Formalin; Tricaine Methanesulfonate", "Rule", "Withdrawal", "2014-01-16T05:00:00Z", 2014, 1, "2014-01-16T05:00:00Z", null, "2014-01-16T15:01:12Z", "2014-00722", 0, 0, "090000648150d714"], ["FDA-2013-N-0002-0045", "FDA", "FDA-2013-N-0002", "New Animal Drugs for Use in Animal Feeds; Bambermycins; Correction", "Rule", "Correction", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2013-12-30T15:28:01Z", "2013-31184", 0, 0, "09000064814e1974"], ["FDA-2013-N-0002-0049", "FDA", "FDA-2013-N-0002", "Approvals of New Animal Drug Applications Withdrawals Roxarsone", "Rule", "Final Rule", "2013-12-27T05:00:00Z", 2013, 12, "2013-12-27T05:00:00Z", null, "2014-01-25T23:25:40Z", "2013-30837", 0, 0, "09000064814de405"], ["FDA-2013-N-0002-0044", "FDA", "FDA-2013-N-0002", "Withdrawal of Approval of New Animal Drug Applications; Roxarsone", "Rule", "Final Rule", "2013-12-27T05:00:00Z", 2013, 12, "2013-12-27T05:00:00Z", null, "2013-12-27T15:39:48Z", "2013-30838", 0, 0, "09000064814de527"], ["FDA-2013-N-0002-0043", "FDA", "FDA-2013-N-0002", "New Animal Drugs for Use in Animal Feeds; Bambermycins", "Rule", "Final Rule", "2013-12-16T05:00:00Z", 2013, 12, "2013-12-16T05:00:00Z", null, "2013-12-16T17:30:57Z", "2013-29810", 0, 0, "09000064814c1cc8"], ["FDA-2013-N-0002-0042", "FDA", "FDA-2013-N-0002", "New Animal Drugs: Hyaluronate Sodium; Hydrogen Peroxide; Imidacloprid and Moxidectin; Change of Sponsor", "Rule", "Final Rule", "2013-12-09T05:00:00Z", 2013, 12, null, null, "2013-12-10T11:17:01Z", "2013-29234", 0, 0, "09000064814b25e6"], ["FDA-2013-N-0002-0041", "FDA", "FDA-2013-N-0002", "Withdrawal of Approval of New Animal Drug Applications; Arsanilic Acid", "Rule", "Final Rule", "2013-11-26T05:00:00Z", 2013, 11, "2013-11-26T05:00:00Z", null, "2013-11-26T14:21:13Z", "2013-28256", 0, 0, "09000064814989b3"], ["FDA-2013-N-0002-0040", "FDA", "FDA-2013-N-0002", "Withdrawal of Approval of New Animal Drug Applications; Arsanilic Acid", "Notice", "General Notice", "2013-11-26T05:00:00Z", 2013, 11, "2013-11-26T05:00:00Z", null, "2013-11-26T14:17:06Z", "2013-28255", 0, 0, "0900006481498795"], ["FDA-2013-N-0002-0039", "FDA", "FDA-2013-N-0002", "Withdrawal of Approval of New Animal Drug Applications; Carbarsone; Roxarsone", "Rule", "Final Rule", "2013-11-22T05:00:00Z", 2013, 11, "2013-11-22T05:00:00Z", null, "2013-11-22T14:42:39Z", "2013-27917", 0, 0, "0900006481491103"], ["FDA-2013-N-0002-0038", "FDA", "FDA-2013-N-0002", "Withdrawal of Approval of New Animal Drug Applications; Carbarsone; Roxarsone", "Notice", "General Notice", "2013-11-22T05:00:00Z", 2013, 11, "2013-11-22T05:00:00Z", null, "2013-11-22T14:37:17Z", "2013-27916", 0, 0, "09000064814910b5"], ["FDA-2013-N-0002-0036", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary NADA 095-735 RUMENSIN 90 Monensin", "Supporting & Related Material", "Freedom of Information Summary", "2013-11-05T05:00:00Z", 2013, 11, null, null, "2013-11-05T17:24:32Z", null, 0, 0, "09000064814711c6"], ["FDA-2013-N-0002-0034", "FDA", "FDA-2013-N-0002", "New Animal Drugs: Afoxolaner, Carprofen, Ceftiofur Hydrochloride, Monensin", "Rule", "Final Rule", "2013-11-05T05:00:00Z", 2013, 11, "2013-11-05T05:00:00Z", null, "2013-11-05T16:41:31Z", "2013-26473", 0, 0, "0900006481470b65"], ["FDA-2013-N-0002-0037", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary NADA 141-288 EXCENEL RTU EZ Ceftiofur Hydrochloride", "Supporting & Related Material", "Freedom of Information Summary", "2013-11-05T05:00:00Z", 2013, 11, null, null, "2013-11-05T17:34:49Z", null, 0, 0, "0900006481471240"], ["FDA-2013-N-0002-0035", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary NADA 141-406 NEXGARD Afoxolaner Chewable Tablet", "Supporting & Related Material", "Freedom of Information Summary", "2013-11-05T05:00:00Z", 2013, 11, null, null, "2013-11-05T17:00:27Z", null, 0, 0, "09000064814706c5"], ["FDA-2013-N-0002-0028", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary NADA 139-237 Lactating Dairy Cows", "Supporting & Related Material", "Freedom of Information Summary", "2013-10-25T04:00:00Z", 2013, 10, null, null, "2013-10-25T13:44:45Z", null, 0, 0, "090000648145e676"], ["FDA-2013-N-0002-0030", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary NADA 141-360 EQUISUL-SDT Sulfadiazine/Trimethoprim Horses", "Supporting & Related Material", "Freedom of Information Summary", "2013-10-25T04:00:00Z", 2013, 10, null, null, "2013-10-25T14:04:49Z", null, 0, 0, "090000648145e7f0"], ["FDA-2013-N-0002-0032", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary ANADA 200-542 ENGAIN 9 and ENGAIN 5 Ractopamine Hydrochloride Finishing Swine", "Supporting & Related Material", "Freedom of Information Summary", "2013-10-25T04:00:00Z", 2013, 10, null, null, "2013-10-25T14:32:31Z", null, 0, 0, "090000648145e8f7"], ["FDA-2013-N-0002-0033", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary ANADA 200-548 ACTOGAIN 45 Ractopamine Hydrochloride Cattle fed in confinement for slaughter", "Supporting & Related Material", "Freedom of Information Summary", "2013-10-25T04:00:00Z", 2013, 10, null, null, "2013-10-25T14:31:20Z", null, 0, 0, "090000648145e8fc"], ["FDA-2013-N-0002-0029", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary NADA 141-349 DRAXXIN 25 Injectable Solution, Tulathromycin, Swine", "Supporting & Related Material", "Freedom of Information Summary", "2013-10-25T04:00:00Z", 2013, 10, null, null, "2013-10-25T13:58:47Z", null, 0, 0, "090000648145e677"], ["FDA-2013-N-0002-0031", "FDA", "FDA-2013-N-0002", "New Animal Drugs; Change of Sponsor: Gonadorelin, Ivermectin, Ractopamine, Trimethoprim and Sulfadiazine Suspension, Tulathromycin", "Rule", "Final Rule", "2013-10-25T04:00:00Z", 2013, 10, "2013-10-25T04:00:00Z", null, "2013-10-25T14:19:29Z", "2013-25172", 0, 0, "090000648145feec"], ["FDA-2013-N-0002-0027", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary ANADA 200-550 MELOXIDYL Meloxicam", "Supporting & Related Material", "Freedom of Information Summary", "2013-09-20T04:00:00Z", 2013, 9, null, null, "2013-09-20T14:17:02Z", null, 0, 0, "090000648142d5dd"], ["FDA-2013-N-0002-0026", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary ANADA 200-514 BOVIPROL 9.6% Oral Solution Amprolium Cattle/Calves", "Supporting & Related Material", "Freedom of Information Summary", "2013-09-20T04:00:00Z", 2013, 9, null, null, "2013-09-20T14:03:03Z", null, 0, 0, "090000648142d5dc"], ["FDA-2013-N-0002-0025", "FDA", "FDA-2013-N-0002", "Oral Dosage Form New Animal Drugs: Amprolium; Meloxicam", "Rule", "Final Rule", "2013-09-17T04:00:00Z", 2013, 9, "2013-09-17T04:00:00Z", null, "2013-09-17T15:23:49Z", "2013-22523", 0, 0, "09000064814276a4"], ["FDA-2013-N-0002-0024", "FDA", "FDA-2013-N-0002", "New Animal Drugs: Carprofen; Enrofloxacin; Florfenicol; Tildipirosin; Zilpaterol", "Rule", "Final Rule", "2013-08-27T04:00:00Z", 2013, 8, "2013-08-27T04:00:00Z", null, "2013-12-10T11:40:18Z", "2013-20538", 0, 0, "09000064813c6a82"], ["FDA-2013-N-0002-0022", "FDA", "FDA-2013-N-0002", "Withdrawal of Approval of New Animal Drug Applications; Quali-Tech Products, Inc.; Bambermycins; Pyrantel; Tylosin; Virginiamycin", "Notice", "Withdrawal", "2013-08-23T04:00:00Z", 2013, 8, "2013-08-23T04:00:00Z", null, "2013-08-23T15:35:16Z", "2013-20615", 0, 0, "09000064813c11f6"], ["FDA-2013-N-0002-0023", "FDA", "FDA-2013-N-0002", "Withdrawal of Approval of New Animal Drug Applications; Quali-Tech Products, Inc.; Bambermycins; Pyrantel; Tylosin; Virginiamycin", "Rule", "Final Rule", "2013-08-23T04:00:00Z", 2013, 8, "2013-08-23T04:00:00Z", null, "2013-08-23T15:22:26Z", "2013-20616", 0, 0, "09000064813c1175"], ["FDA-2013-N-0002-0021", "FDA", "FDA-2013-N-0002", "New Animal Drugs; Change of Sponsor; Fentanyl; Iron Injection", "Rule", "Final Rule", "2013-07-24T04:00:00Z", 2013, 7, "2013-07-24T04:00:00Z", null, "2013-07-24T14:40:15Z", "2013-17754", 0, 0, "0900006481379e58"], ["FDA-2013-N-0002-0019", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary NADA 141-345 APOQUEL (oclacitinib tablet)", "Supporting & Related Material", "Freedom of Information Summary", "2013-07-15T04:00:00Z", 2013, 7, null, null, "2013-07-15T15:48:56Z", null, 0, 0, "0900006481366402"], ["FDA-2013-N-0002-0018", "FDA", "FDA-2013-N-0002", "Oral Dosage Form New Animal Drugs; Nicarbazin; Oclacitinib; Zilpaterol", "Rule", "Final Rule", "2013-07-15T04:00:00Z", 2013, 7, "2013-07-15T04:00:00Z", null, "2013-07-15T15:40:23Z", "2013-16258", 0, 0, "09000064813666f8"], ["FDA-2013-N-0002-0020", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary ANADA 200-544 ZILMAX plus RUMENSIN plus TYLOVET 100 plus MGA", "Supporting & Related Material", "Reference (internal unless indicated)", "2013-07-15T04:00:00Z", 2013, 7, null, null, "2013-07-15T15:56:17Z", null, 0, 0, "0900006481366403"], ["FDA-2013-N-0002-0017", "FDA", "FDA-2013-N-0002", "New Animal Drugs; Dexmedetomidine; Lasalocid; Melengestrol; Monensin; and Tylosin; Correction", "Rule", "Correction", "2013-06-05T04:00:00Z", 2013, 6, "2013-06-05T04:00:00Z", null, "2013-06-05T14:01:32Z", "2013-13331", 0, 0, "090000648130b953"], ["FDA-2013-N-0002-0016", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary ANADA 200-551 Enrofloxacin Flavored Tablets", "Supporting & Related Material", "Freedom of Information Summary", "2013-05-22T04:00:00Z", 2013, 5, null, null, "2013-05-22T14:18:38Z", null, 0, 0, "09000064812f25ab"], ["FDA-2013-N-0002-0014", "FDA", "FDA-2013-N-0002", "Oral Dosage Form New Animal Drugs; Clindamycin; Enrofloxacin", "Rule", "Final Rule", "2013-05-22T04:00:00Z", 2013, 5, "2013-05-22T04:00:00Z", null, "2013-05-22T13:54:39Z", "2013-12134", 0, 0, "09000064812f2154"], ["FDA-2013-N-0002-0015", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary ANADA 200-538 CLINDAMED Oral Drops", "Supporting & Related Material", "Freedom of Information Summary", "2013-05-22T04:00:00Z", 2013, 5, null, null, "2013-05-22T14:09:47Z", null, 0, 0, "09000064812f2586"], ["FDA-2013-N-0002-0013", "FDA", "FDA-2013-N-0002", "New Animal Drugs; Change of Sponsor's Name and Address; Change of Sponsor", "Rule", "Final Rule", "2013-05-13T04:00:00Z", 2013, 5, "2013-05-13T04:00:00Z", null, "2013-05-13T13:30:45Z", "2013-11283", 0, 0, "09000064812dfc63"], ["FDA-2013-N-0002-0012", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary ANADA 200-535 Melengestrol acetate plus lasalocid sodium plus tylosin phosphate", "Supporting & Related Material", "Freedom of Information Summary", "2013-04-30T04:00:00Z", 2013, 4, null, null, "2013-04-30T14:12:34Z", null, 0, 0, "09000064812ad2f7"], ["FDA-2013-N-0002-0010", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary ANADA 200-532 MGA plus TYLOVET 100", "Supporting & Related Material", "Freedom of Information Summary", "2013-04-30T04:00:00Z", 2013, 4, null, null, "2013-04-30T13:49:36Z", null, 0, 0, "09000064812ad28f"], ["FDA-2013-N-0002-0009", "FDA", "FDA-2013-N-0002", "New Animal Drugs; Dexmedetomidine; Lasalocid; Melengestrol; Monensin; and Tylosin", "Rule", "Final Rule", "2013-04-30T04:00:00Z", 2013, 4, "2013-04-30T04:00:00Z", null, "2013-04-30T13:30:05Z", "2013-10152", 0, 0, "09000064812ad9a8"], ["FDA-2013-N-0002-0011", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary ANADA 200-533 DECCOX plus RUMENSIN plus TYLOVET 100 (decoquinate plus monensin USP plus tylosin phosphate)", "Supporting & Related Material", "Reference (internal unless indicated)", "2013-04-30T04:00:00Z", 2013, 4, null, null, "2013-04-30T14:03:23Z", null, 0, 0, "09000064812ad2f5"], ["FDA-2013-N-0002-0008", "FDA", "FDA-2013-N-0002", "New Animal Drugs: Change of Sponsor", "Rule", "Final Rule", "2013-04-09T04:00:00Z", 2013, 4, "2013-04-09T04:00:00Z", null, "2013-04-09T14:02:58Z", "2013-07542", 0, 0, "0900006481289e2d"], ["FDA-2013-N-0002-0005", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary re Abbreviated New Animal Drug Application ANADA 200-495 ENROFLOX 100 Enrofloxacin Injectable Solution Beef and Non-Lactating Dairy Cattle Swine", "Supporting & Related Material", "Freedom of Information Summary", "2013-04-03T04:00:00Z", 2013, 4, null, null, "2013-12-10T12:05:33Z", null, 0, 0, "09000064812642ee"], ["FDA-2013-N-0002-0007", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary re Abbreviated New Animal Drug Application ANADA 20TYLOVET 100 Tylosin Phosphate and RUMENSIN Monensin 200-531 Type Articles For Use in the Manufacture of Type B and Medicated Feeds", "Supporting & Related Material", "Freedom of Information Summary", "2013-04-03T04:00:00Z", 2013, 4, null, null, "2013-12-10T12:09:28Z", null, 0, 0, "0900006481264a82"], ["FDA-2013-N-0002-0004", "FDA", "FDA-2013-N-0002", "New Animal Drugs: Enrofloxacin; Tilmicosin; Tylosin", "Rule", "Final Rule", "2013-04-03T04:00:00Z", 2013, 4, "2013-04-03T04:00:00Z", null, "2013-04-03T15:12:51Z", "2013-07571", 0, 0, "0900006481263219"], ["FDA-2013-N-0002-0006", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary re Abbreviated New Animal Drug Application ANADA 200-509 TILMOVET 90 Tilmicosin Phosphate Type A Medicated Article", "Supporting & Related Material", "Freedom of Information Summary", "2013-04-03T04:00:00Z", 2013, 4, null, null, "2013-12-10T12:11:23Z", null, 0, 0, "0900006481264910"], ["FDA-2013-N-0002-0003", "FDA", "FDA-2013-N-0002", "Freedom of Information Summary ANADA 200-541 GONABREED Gonadorelin Acetate Injectable Solution Dairy Cattle", "Supporting & Related Material", "Freedom of Information Summary", "2013-03-26T04:00:00Z", 2013, 3, null, null, "2013-12-10T11:54:59Z", null, 0, 0, "0900006481243b6a"], ["FDA-2013-N-0002-0002", "FDA", "FDA-2013-N-0002", "New Animal Drug Approvals: Change of Sponsor; Change of Sponsor's Drug Labeler Code; Gonadorelin Acetate; Isoflurane; Praziquantel; Propofol; Sevoflurane; Triamcinolone Acetonide", "Rule", "Final Rule", "2013-03-25T04:00:00Z", 2013, 3, "2013-03-25T04:00:00Z", null, "2013-12-10T11:54:02Z", "2013-06748", 0, 0, "090000648124175f"], ["FDA-2013-N-0002-0001", "FDA", "FDA-2013-N-0002", "New Animal Drugs: Sponsor Changes", "Rule", "Final Rule", "2013-03-22T04:00:00Z", 2013, 3, "2013-03-22T04:00:00Z", null, "2013-03-22T13:17:57Z", "2013-06126", 0, 0, "090000648123d536"]], "truncated": false, "filtered_table_rows_count": 59, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2013-N-0002"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0002", "results": [{"value": "FDA", "label": "FDA", "count": 59, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-N-0002", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0002", "results": [{"value": "Rule", "label": "Rule", "count": 26, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0002&document_type=Rule", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 26, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0002&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0002&document_type=Other", "selected": false}, {"value": "Notice", "label": "Notice", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0002&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0002", "results": [{"value": 2013, "label": 2013, "count": 46, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0002&posted_year=2013", "selected": false}, {"value": 2014, "label": 2014, "count": 13, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0002&posted_year=2014", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0002&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0002&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0002&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0002&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0002&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0002&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0002&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1193.2224080665037, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}